LED Medical Announces US Distribution Agreement with Benco Dental
Burnaby, B.C. — LED Medical Diagnostics Inc. ("LED Medical" or the "Company") is pleased to announce that its wholly-owned subsidiary, LED Dental Inc. ("LED Dental"), has entered into a non-exclusive partnership with Benco Dental ("Benco") for the distribution of the Company's VELscope® Vx Enhanced Oral Assessment System and product line within the United States market.
"We are pleased to partner with Benco for distribution in the United States," stated Dr. David Gane, CEO for LED Medical. "Benco currently serves more than 35,000 customers across the country and maintains an excellent reputation in the dental industry. We are excited about the opportunity to work together, maximizing the significant sales potential for the VELscope® Vx product line through its extensive network."
"We are pleased to now carry the VELscope® Vx product line for our customers," states Chuck Cohen, Managing Director of Benco Dental. "LED Dental has established itself as the market leader for tissue fluorescence visualization in the dental industry and the VELscope® Vx system has proven itself as the top adjunctive device available for the early discovery of a wide range oral abnormalities including oral cancer. It is a welcome addition to the portfolio of outstanding equipment lines we carry at Benco."
LED Medical Announces US Distribution Agreement with Burkhart Dental Supply
Burnaby, B.C. — LED Medical Diagnostics Inc. ("LED Medical, the Company") is pleased to announce that its wholly‐owned subsidiary, LED Dental Inc., has entered into a non‐exclusive partnership with Burkhart Dental Supply ("Burkhart") for the distribution of the company's VELscope® Vx Enhanced Oral Assessment System and product line within the United States market.
"We are pleased to partner with Burkhart, one of the most respected dental supply companies in the United States," stated Dr. David Gane, CEO for LED Medical. "For over 125 years Burkhart has been committed to serving dental practitioners with quality equipment and supplies, comprehensive product training, as well as strong after‐sales support. Their strong market presence and deep network is ideally suited to our expansion strategy for the VELscope® Vx product line in the United States."
"We are pleased to carry the VELscope Vx product line for our US network," states Lori Burkhart Isbell, President of Burkhart. "The VELscope® Vx sets the standard for tissue fluorescence visualization and is a market leading adjunctive oral mucosal examination tool that is in demand with our client base. It has also proven to be highly effective for the early detection of oral cancer and pre‐cancers, and we support it as an important, potentially life‐saving device."